Institute of Science Tokyo · Graduate School of Medical and Dental Sciences · 准教授

Research keywordschronic active EBV disease・Epstein-Barr virus microRNA・anti-EBV antibodies・venetoclax therapy・hematopoietic stem cell transplantation・interferon-gamma biomarker・cleanroom microbial risk assessment・biosafety cabinet decontamination・cell product cross-contamination・airborne bacterial microbiome

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Mizuno M, Ogata Y, Nishihara Y, Nishio M, Katano H, Sekiya I.. Microbiome-based profiles of airborne bacteria to support microbial risk assessment in cleanroom environments Regenerative Therapy. 2025.11; 30 991-998.2025
• Expression profiling of Epstein-Barr virus-derived microRNA in systemic chronic active EBV disease. 2025.07; ( PubMed , DOI )2025
• 井上栞杏、一ノ瀬彩加、竹内あずさ、佐伯久美子、西尾美和子. 褐色脂肪細胞の人工作製技術の開発 BIO INDUSTRY. 2025.02; 42 (2): 17-22.2025
• Effects of venetoclax, a BCL2 inhibitor, in systemic chronic active Epstein-Barr virus disease. 2025.05; 15 (1): 18569. ( PubMed , DOI )2025

• Official profile